Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Novel approaches to female sexual dysfunction
Autore:
Berman, LA; Berman, JR; Chhabra, S; Goldstein, I;
Indirizzi:
Boston Univ, Med Ctr, Div Urol, Boston, MA 02215 USA Boston Univ Boston MA USA 02215 , Med Ctr, Div Urol, Boston, MA 02215 USA
Titolo Testata:
EXPERT OPINION ON INVESTIGATIONAL DRUGS
fascicolo: 1, volume: 10, anno: 2001,
pagine: 85 - 95
SICI:
1354-3784(200101)10:1<85:NATFSD>2.0.ZU;2-I
Fonte:
ISI
Lingua:
ENG
Soggetto:
CLITORAL ERECTILE INSUFFICIENCY; VAGINAL ENGORGEMENT; WOMEN; PREVALENCE; SILDENAFIL; MENOPAUSE; AROUSAL;
Keywords:
apomorphine; female pelvic anatomy; female sexual disorders; female sexual dysfunction; L-arginine; methyltestosterone; neurogenic mediators; oestrogen; phentolamine; prostaglandin E1; sildenafil; testosterone; yohimbine;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
32
Recensione:
Indirizzi per estratti:
Indirizzo: Berman, LA Boston Univ, Med Ctr, Div Urol, 720 Harrison Ave,Suite 606, Boston, MA 02215 USA Boston Univ 720 Harrison Ave,Suite 606 Boston MA USA 02215 USA
Citazione:
L.A. Berman et al., "Novel approaches to female sexual dysfunction", EXPERT OP I, 10(1), 2001, pp. 85-95

Abstract

Female sexual dysfunction is age-related, progressive and highly prevalent, affecting 30 - 50% of American women. While there are emotional and relational elements to sexual function, it has become increasingly evident that female sexual dysfunction can occur secondary to medical problems and has an organic basis. A plethora of different female sexual dysfunctions exist and in order to obtain a greater understanding of the possible treatments for these problems, it is essential to have a strong knowledge base of femalepelvic anatomy, the neurogenic mediators of female sexual response, the impact of hormones on female sexual function and the aetiologies of female sexual dysfunction. Currently, there are potential therapeutic options for the treatment of female sexual dysfunction and these options include both hormonal and pharmacological therapy. However, therapeutic agents may not prove to be enough and the ideal approach to female sexual dysfunction is thus a collaborative effort between therapists and physicians, which should include a complete medical and psychosocial evaluation, as well as inclusion ofthe partner or spouse in the evaluation and treatment process.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 19:28:44